Andrew Dallas Boyd

Andrew Dallas Boyd

Auto-generated profile, based on publicly available information

Andrew Dallas Boyd

Department of Biomedical and Health Information Sciences, College of Applied Health Science, University of Illinois Chicago, Chicago, IL

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2005 in Nucleic Acids Research
Verified
Journal Article
Open access
MDManhong Dai
Manhong Dai
PWPinglang Wang
Pinglang Wang
ABAndrew D Boyd
Andrew D Boyd
GKGeorgi Kostov
Georgi Kostov
BABrian Athey
Brian Athey
FMFan Meng
Fan Meng
Genome-wide expression profiling is a powerful tool for implicating novel gene ensembles in cellular mechanisms of health and disease. The most popular platform for genome-wide expression profiling is the Affymetrix GeneChip. However, its selection of probes relied on earlier genome and transcriptome annotation which is significantly different from current knowledge. The resultant informatics problems have a profound impact on analysis and interpretation the data. Here, we address these critical issues and offer a solution. We identified several classes of problems at the individual probe level in the existing annotation, under the assumption that current genome and transcriptome databases are more accurate than those used for GeneChip design. We then reorganized probes on more than a dozen popular GeneChips into gene-, transcript- and exon-specific probe sets in light of up-to-date genome, cDNA/EST clustering and single nucleotide polymorphism information. Comparing analysis results between the original and the redefined probe sets reveals approximately 30-50% discrepancy in the genes previously identified as differentially expressed, regardless of analysis method. Our results demonstrate that the original Affymetrix probe set definitions are inaccurate, and many conclusions derived from past GeneChip analyses may be significantly flawed. It will be beneficial to re-analyze existing GeneChip data with updated probe set definitions.

28 June 2021 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Open access
JTJulian Theis
Julian Theis
WGWilliam L. Galanter
William L. Galanter
ABAndrew D. Boyd
Andrew D. Boyd
Houshang DarabiHoushang Darabi
Houshang Darabi
Diabetes intensive care unit (ICU) patients are at increased risk of complications leading to in-hospital mortality. Assessing the likelihood of death is a challenging and time consuming task due to a large number of influencing factors. Healthcare providers are interested in the detection of ICU patients at higher risk, such that risk factors can possibly be mitigated. While such severity scoring methods exist, they are commonly based on a snapshot of the health conditions of a patient during the ICU stay and do not specifically consider a patient's prior medical history. In this paper, a process mining/deep learning architecture is proposed to improve established severity scoring methods by incorporating the medical history of diabetes patients. First, health records of past hospital encounters are converted to event logs suitable for process mining. The event logs are then used to discover a process model that describes the past hospital encounters of patients. An adaptation of Decay Replay Mining is proposed to combine medical and demographic information with established severity scores to predict the in hospital mortality of diabetes ICU patients. Significant performance improvements are demonstrated compared to established risk severity scoring methods and machine learning approaches using the Medical Information Mart for Intensive Care III dataset.

1 May 2007 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
ABAndrew D. Boyd
Andrew D. Boyd
CHCharlie Hosner
Charlie Hosner
DHDale A. Hunscher
Dale A. Hunscher
BABrian D. Athey
Brian D. Athey
DCDaniel J. Clauw
Daniel J. Clauw
LGLee A. Green
Lee A. Green

26 June 2023 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
ABAndrew D Boyd
Andrew D Boyd
RGRosa Gonzalez-Guarda
Rosa Gonzalez-Guarda
KLKatharine Lawrence
Katharine Lawrence
CPCrystal L Patil
Crystal L Patil
MEMiriam O Ezenwa
Miriam O Ezenwa
JSJudith M Schlaeger
Judith M Schlaeger
Embedded pragmatic clinical trials (ePCTs) play a vital role in addressing current population health problems, and their use of electronic health record (EHR) systems promises efficiencies that will increase the speed and volume of relevant and generalizable research. However, as the number of ePCTs using EHR-derived data grows, so does the risk that research will become more vulnerable to biases due to differences in data capture and access to care for different subsets of the population, thereby propagating inequities in health and the healthcare system. We identify 3 challenges—incomplete and variable capture of data on social determinants of health, lack of representation of vulnerable populations that do not access or receive treatment, and data loss due to variable use of technology—that exacerbate bias when working with EHR data and offer recommendations and examples of ways to actively mitigate bias.

1 July 2013 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
ABAndrew D Boyd
Andrew D Boyd
JLJianrong ‘jOhn’ Li
Jianrong ‘jOhn’ Li
MBMike D Burton
Mike D Burton
MJMichael Jonen
Michael Jonen
VGVincent Gardeux
Vincent Gardeux
Yves LussierYves Lussier
Yves Lussier
Objective Applying the science of networks to quantify the discriminatory impact of the ICD-9-CM to ICD-10-CM transition between clinical specialties.

28 August 2009 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
ABAndrew D. Boyd
Andrew D. Boyd
PSPaul R. Saxman
Paul R. Saxman
DHDale A. Hunscher
Dale A. Hunscher
KSKevin A. Smith
Kevin A. Smith
TMTimothy D. Morris
Timothy D. Morris
BABrian D. Athey
Brian D. Athey
For the success of clinical and translational science, a seamless interoperation is required between clinical and research information technology. Ad